The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry.

Expert review of gastroenterology & hepatology(2023)

引用 7|浏览13
暂无评分
摘要
Patients treated with CBMPs for refractory symptoms of Crohn's disease and ulcerative colitis demonstrated a short-term improvement in IBD-specific and general HRQoL. Prior cannabis consumers reported greater improvement compared to cannabis-naïve individuals.
更多
查看译文
关键词
IBD,clinical outcomes,inflammatory bowel disease,medical cannabis,medicinal marijuana
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要